The potential regulatory role of RNA methylation in ovarian cancer
Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Shijie Zhao1, Mengxue Zhang1, Xiaolan Zhu2
1Department of Central Laboratory, The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Abstract:
Updates in whole genome sequencing technologies have revealed various RNA modifications in cancer, among which RNA methylation is a frequent posttranscriptional modification. RNA methylation is essential for regulating biological processes such as RNA transcription, splicing, structure, stability, and translation. Its dysfunction is strongly associated with the development of human malignancies. Research advances with respect to the regulatory role of RNA modifications in ovarian cancer include N6-methyladenosine (m6A), 5-methylcytosine (m5C), N1-methyladenosine (m1A), and N7-methylguanosine (m7G). Numerous studies have demonstrated that epigenetic modifications of RNA can influence the progression and metastasis of ovarian cancer and may provide excellent targets for cancer therapy. This review highlights advances in research on RNA methylation modifications and ovarian cancer prognosis, carcinogenesis, and resistance, which could provide a theoretical foundation for designing therapeutic strategies for ovarian cancer based on RNA methylation modifications.
Insights
RNA methylation, crucial for gene regulation, is frequently altered in ovarian cancer. Understanding these epigenetic changes offers new therapeutic targets for this malignancy.
Area of Science:
- Molecular Biology
- Genomics
- Oncology
Background:
- Whole genome sequencing reveals diverse RNA modifications in cancer.
- RNA methylation is a key posttranscriptional modification regulating gene expression.
- Dysfunctional RNA methylation is linked to human malignancy development.
Purpose of the Study:
- To review advances in RNA methylation research concerning ovarian cancer.
- To explore the role of RNA methylation in ovarian cancer prognosis, carcinogenesis, and resistance.
- To provide a foundation for developing RNA methylation-based therapeutic strategies for ovarian cancer.
Main Methods:
- Literature review of studies on RNA methylation and ovarian cancer.
- Analysis of research on specific RNA modifications like m6A, m5C, m1A, and m7G.
- Synthesis of findings on the impact of RNA epigenetic modifications on cancer progression.
Main Results:
- N6-methyladenosine (m6A), 5-methylcytosine (m5C), N1-methyladenosine (m1A), and N7-methylguanosine (m7G) are key RNA modifications in ovarian cancer.
- Epigenetic RNA modifications influence ovarian cancer progression, metastasis, and therapeutic resistance.
- RNA methylation plays a significant role in ovarian cancer development and prognosis.
Conclusions:
- RNA methylation modifications are critical in ovarian cancer.
- Targeting RNA methylation pathways presents promising therapeutic avenues for ovarian cancer.
- Further research into RNA methylation can inform novel treatment strategies for ovarian cancer.
More Related Videos
Related Concept Videos
MicroRNAs
Epigenetic Regulation
RNA Stability
Experimental RNAi
Regulation of Expression at Multiple Steps
Types of RNA
RNA Performs Diverse...

